Khalit Mustafin

Khalit Mustafin

Auto-generated profile, based on publicly available information

Khalit Mustafin

National Center of Neurosurgery

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2019 in Cancer Management and Research
Verified
Journal Article
Open access
PDF file
RARaushan Auezova
Raushan Auezova
NINatalia Ivanova
Natalia Ivanova
SASerik Akshulakov
Serik Akshulakov
BZBerik Zhetpisbaev
Berik Zhetpisbaev
AKAizhan Kozhakhmetova
Aizhan Kozhakhmetova
LALizette Auezova
Lizette Auezova
Background: Glioma patients with mutant isocitrate dehydrogenase have improved survival; this could be in part due to the suppressive effect of mutant IDH on the level of chronic inflammation. This study aimed to prospectively analyze the association of IDH1 mutation status with preoperative levels of blood inflammatory markers: neutrophil–lymphocyte ratio (NLR), platelet–lymphocyte ratio (PLR), C-reactive protein (CRP), and red cell distribution width (RDW) in gliomas. Patients and methods: Receiver operating characteristic curves for cutoff value determination, various bivariate tests, and survival analyses (Kaplan–Meier curves and Cox regression) were performed. Results: Patients with mutant IDH1 had reduced levels of NLR (P<0.032) and CRP (P<0.008). Moreover, these patients showed better median overall survival compared to those without IDH1 mutation (P<0.000). In univariate analysis, IDH1 mutation status (P<0.000), NLR (P<0.000), PLR (P<0.008), and CRP (P<0.001) were among the factors associated with survival. By multivariate analysis, IDH1 mutation (P<0.044) and NLRP<0.022) remained independent factors associated with better survival; other independent variables were tumor grade (P<0.000) and location in noneloquent area (P<0.015). Conclusion: The obtained results show that IDH1 mutation is associated with lower levels of chronic inflammation that could account for an improved prognosis in this group of patients.

28 November 2018 in Current Medical Research and Opinion
Verified
Journal Article
Closed access
Kuat OshakbayevKuat Oshakbayev
Kuat Oshakbayev
BBBakytzhan Bimbetov
Bakytzhan Bimbetov
KMKenzhegul Manekenova
Kenzhegul Manekenova
GBGulnara Bedelbayeva
Gulnara Bedelbayeva
KMKhalit Mustafin
Khalit Mustafin
BDBibazhar Dukenbayeva
Bibazhar Dukenbayeva
Objective: To evaluate the effectiveness of the fast weight loss method on liver steatosis, fibrosis, inflammation, glycemic and lipids features and body composition in patients with severe Nonalcoholic Steatohepatitis (NASH) and Type 2 Diabetes (T2D). Methods: A 24-week open prospective randomised controlled clinical trial including 80 adult patients (aged 40-65 years) was performed. The patients after randomisation were divided in two groups: Main group followed the fast weight loss method; Control group received conventional drug treatment. The fast weight loss method included calorie restriction, salt intake, walking and sexual self-restraint. The conventional drug therapy included Vitamin E, Orlistat, Pioglitazone hydrochloride, Atorvastatin, Lisinopril, benzodiazepines and anti-inflammatory agents. Primary endpoints: ultrasound and histology suggestive of steatohepatitis, hepatic enzymes, weight loss, 2-hour oral glucose tolerance test, HbA1c. Secondary endpoints: blood pressure, lipids. Results: 83% patients completed the study. In Main weight lost 7-16 kg (10-20% from baseline) for 8-10 weeks. In Main weight lost due to reduction of fat mass only. Main vs. Controls showed higher decrease in fat mass from baseline (P < 0.001). Ultrasound imaging and liver histological scoring system evidenced significant improvement on liver steatosis/fibrosis in Main (P < 0.001). In Main vs. Controls weight lost at 24 weeks led to positive laboratory changes in ALT, AST, 2-hour OGTT, HbA1c, HOMA-IR, BP, cholesterol, triglycerides, bilirubin total, blood hemoglobin (P = 0.01). The fast weight loss in the patients adequately led to decrease in symptomatic drugs up to complete abolition. Conclusions: The study showed benefits of the fast weight loss method improving in steatosis/fibrosis, biochemical/metabolic outcomes in patients with severe NASH and T2D.

21 December 2017 in Gynecological Endocrinology
Verified
Journal Article
Open access
DTDaniyar Teltayev
Daniyar Teltayev
SASerik Akshulakov
Serik Akshulakov
NRNurzhan Ryskeldiev
Nurzhan Ryskeldiev
KMKhalit Mustafin
Khalit Mustafin
VLVyacheslav Notanovich Lokshin
Vyacheslav Notanovich Lokshin
Acromegaly is one of the most common syndromes in pituitary adenomas. Naturally, women with this condition have trouble with their reproductive function. The difficulty in diagnosing acromegaly progression in pregnancy is that there is also production of placental growth hormone observed, making it impossible to differentiate from neoplastic growth hormone production using conventional methods of investigation. This article is about a clinical case of acromegaly in a 22 years old woman who was operated on using transnasal transsphenoidal approach and received postoperative treatment with somatostatin analog – lanreotide acetate autogel – for six months. The woman became pregnant in the course of the treatment. During pregnancy, the GH and IGF-I levels in serum remained within normal limits. Lanreotide acetate therapy was discontinued. The woman successfully gave birth to a healthy baby. There was a remission of the disease after pregnancy.

8 April 2019 in Current Medical Research and Opinion
Verified
Journal Article
Closed access
Kuat OshakbayevKuat Oshakbayev
Kuat Oshakbayev
BBBakytzhan Bimbetov
Bakytzhan Bimbetov
KMKenzhegul Manekenova
Kenzhegul Manekenova
GBGulnara Bedelbayeva
Gulnara Bedelbayeva
KMKhalit Mustafin
Khalit Mustafin
BDBibazhar Dukenbayeva
Bibazhar Dukenbayeva
Response: Letter: Non-alcoholic steatohepatitis and type 2 diabetes mellitus: the effects of weight loss versus drug treatment. Current Medical Research and Opinion. Accepted 27 February 2019.

3 April 2026 in Burdenko's Journal of Neurosurgery
Verified
Journal Article
Closed access
EKE.N. Kuanyshev
E.N. Kuanyshev
BSB.S. Syzdykova
B.S. Syzdykova
DTDaniyar Teltayev
Daniyar Teltayev
KMK.H. Mustafin
K.H. Mustafin
Background. Watertight dural closure and skull base reconstruction remain key challenges in neurosurgery. Autologous fibrin sealant Vivostat, produced from the patient’s own blood, provides high biocompatibility, elasticity, and reliable adhesion. The absence of clinical data on its use in Central Asian countries highlights the relevance of the present study. Objective. To evaluate the clinical efficacy and safety of autologous fibrin sealant Vivostat for dural sealing and skull base reconstruction. Material and methods. This retrospective-prospective study included 110 patients operated on at the National Center of Neurosurgery (Astana, Kazakhstan) between August 2024 and September 2025. The sealant, derived from autologous blood using the Vivostat system, was applied for dural defect sealing and fixation of reconstructive grafts. The primary outcomes were the incidence of postoperative cerebrospinal fluid (CSF) leakage, infectious complications, and the need for reoperation. Results. The mean patient age was 48.9±14.7 years; 60% were women. An endoscopic transnasal approach was used in 65 patients, craniotomy in 35, and other approaches in 10. Polymerization occurred almost instantly, reaching maximal strength within 1—2 minutes. Successful sealing was achieved in 109 (99.1%) patients, while 1 (0.9%) patient required reoperation due to nasal CSF leakage and epistaxis. No infectious, allergic, or thromboembolic complications were observed. Conclusion. The use of autologous fibrin sealant Vivostat demonstrated high efficacy and safety for dural sealing and skull base reconstruction. The method reduced the risk of postoperative CSF leakage and reoperation. This study presents the first clinical experience with Vivostat in Central Asia.

31 December 2025 in BULLETIN OF SURGERY OF KAZAKHSTAN
Verified
Journal Article
Closed access
KMK Mustafin
K Mustafin
KTK Tankacheev
K Tankacheev
SDS Duisenbay
S Duisenbay
DZDaniyar Qudyruly Zhamoldin
Daniyar Qudyruly Zhamoldin
YSY Serikbayeva
Y Serikbayeva
DTDaniyar Teltayev
Daniyar Teltayev
Post-traumatic neuromas are a common complication of peripheral nerve injuries, often resulting in chronic pain, as well as sensory and motor dysfunction. The ulnar and median nerves are most frequently affected. The high incidence of neuroma formation and its significant impact on patients’ quality of life highlight the importance of effective surgical management. Intraoperative ultrasound is increasingly being utilized in neuroma surgery, offering real-time visualization of nerve pathology, although its routine use remains limited. This paper presents a clinical case of a 27-year-old patient with a recurrent post-traumatic neuroma of the left median nerve. The patient had undergone multiple previous surgeries, including primary neurorrhaphy and revision neurolysis. Due to persistent neuropathic symptoms, a revision surgery was performed with the use of intraoperative ultrasound, which enabled accurate identification of the neuroma, evaluation of lesion extent, and precise delineation of resection margins. Early postoperative outcomes demonstrated reduced pain, decreased swelling, stabilization of neurological function, and no recurrence on follow-up ultrasound. This case illustrates the potential of intraoperative ultrasound as a safe and effective tool that can improve surgical precision and reduce the risk of neuroma recurrence.